Source: Annual Congress 2006 - COPD exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Ting, G. South, S. W. Crookes (Chesterfield, United Kingdom). Pilot study to assess short-term effect of influenza vaccination on exacerbations of COPD. Eur Respir J 2006; 28: Suppl. 50, 1080

Member's Comments

No comment yet.

Related content which might interest you: Comparison of efficacy of grippe vaccination in asthma and COPD patients Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Comparison of efficacy of grippe vaccination and broncho vaxom administration in COPD patients Source: International Congress 2015 – Different data in COPD Year: 2015 Persistence to COPD therapies and impact on exacerbations: a French claims data study Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Clinical efficacy of pneumococcal vaccine in COPD patients. preliminary results Source: Eur Respir J 2003; 22: Suppl. 45, 408s Year: 2003 Clinical effect of different pneumococcal vaccination schedules in patients with chronic obstructive pulmonary disease (COPD): long-term follow-up results Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Pneumococcal vaccination in chronic respiratory patients – a cohort study Source: International Congress 2019 – Airway infection in COPD Year: 2019 Real-life effectiveness data on prevention OF COPD and asthma exacerbations with 13-valent pneumococcal conjugate vaccine (PCV13) Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 The long-term clinical and economic impact of COPD exacerbations: an observational study (SHERLOCK) Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases Year: 2020 Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Seasonal influenza vaccination rates in chronic asthma patients Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Can the influenza vaccine response be predicted in COPD patients by clinical parameters? Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Impact of influenza vaccination in patients with CAP Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Pneumococcal vaccination: Effects on exacerbation of COPD Source: Annual Congress 2013 –COPD treatment Year: 2013 Initial observed improvement in medication adherence maintained during the COVID-19 pandemic in asthma and COPD Source: Virtual Congress 2021 – Remote monitoring of respiratory patients Year: 2021 A randomised clinical trial to assess the effect of active muscle stimulation on hospitalised patients with COPD exacerbations Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012 A retrospective cohort study demonstrating the impact of an OPEP device on exacerbations in COPD patients with chronic bronchitis Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 The importance of pneumococcal and influenza vaccines in patients with allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 376s Year: 2005 A global survey conducted to determine frequency of exacerbations in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013